{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:23:03Z","timestamp":1790623383410,"version":"4.1.0"},"reference-count":172,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2007,8,17]],"date-time":"2007-08-17T00:00:00Z","timestamp":1187308800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmied Arch Pharmacol"],"published-print":{"date-parts":[[2007,10,4]]},"DOI":"10.1007\/s00210-007-0179-1","type":"journal-article","created":{"date-parts":[[2007,8,16]],"date-time":"2007-08-16T11:40:01Z","timestamp":1187264401000},"page":"45-63","source":"Crossref","is-referenced-by-count":169,"title":["Cardiovascular responses produced by 5-hydroxytriptamine:a pharmacological update on the receptors\/mechanisms involved and therapeutic implications"],"prefix":"10.1007","volume":"376","author":[{"given":"Carlos M.","family":"Villal\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Centuri\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,8,17]]},"reference":[{"key":"179_CR1","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1073\/pnas.90.2.408","volume":"90","author":"N Adham","year":"1993","unstructured":"Adham N, Kao HT, Schechter LE, Bard J, Olsen M, Urquhart D, Durkin M, Hartig PR, Weinshank RL, Branchek TA (1993) Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase. Proc Nat Acad Sci U S A 90:408\u2013412","journal-title":"Proc Nat Acad Sci U S A"},{"key":"179_CR2","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/j.1476-5381.1992.tb13401.x","volume":"107","author":"IK Anderson","year":"1992","unstructured":"Anderson IK, Martin GR, Ramage AG (1992) Central administration of 5-HT activates 5-HT1A receptors to cause sympathoexcitation and 5-HT2\/5-HT1C receptors to release vasopression in anaesthetized rats. Br J Pharmacol 107:1020\u20131028","journal-title":"Br J Pharmacol"},{"key":"179_CR3","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1111\/j.1476-5381.1995.tb16658.x","volume":"116","author":"IK Anderson","year":"1995","unstructured":"Anderson IK, Martin GR, Ramage AG (1995) Evidence that activation of 5-HT2 receptors in the brain of anaesthetized cats causes sympathoexcitation. Br J Pharmacol 116:1751\u20131756","journal-title":"Br J Pharmacol"},{"key":"179_CR4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1476-5381.1976.tb10398.x","volume":"58","author":"E Apperley","year":"1976","unstructured":"Apperley E, Humphrey PP, Levy GP (1976) Receptors for 5-hydroxytryptamine and noradrenaline in rabbit isolated ear artery and aorta. Br J Pharmacol 58:211\u2013221","journal-title":"Br J Pharmacol"},{"key":"179_CR5","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","volume":"38","author":"NM Barnes","year":"1999","unstructured":"Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083\u20131152","journal-title":"Neuropharmacology"},{"key":"179_CR6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF00173574","volume":"339","author":"H Berthold","year":"1989","unstructured":"Berthold H, Scholtysik G, Engel G (1989) Inhibition of the 5-HT-induced cardiogenic hypertensive chemoreflex by the selective 5-HT3 receptor antagonist ICS 205\u2013930. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 339:259\u2013262","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"179_CR7","first-page":"IV161","volume":"21","author":"GW Bielenberg","year":"1990","unstructured":"Bielenberg GW, Burkhardt M (1990) 5-hydroxytryptamine1A agonists. A new therapeutic principle for stroke treatment. Stroke 21:IV161\u2013IV163","journal-title":"Stroke"},{"key":"179_CR8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/sj.bjp.0706966","volume":"150","author":"JA Birkeland","year":"2007","unstructured":"Birkeland JA, Sjaastad I, Brattelid T, Qvigstad E, Moberg ER, Krobert KA, Bjornerheim R, Skomedal T, Sejersted OM, Osnes JB, Levy FO (2007) Effects of treatment with a 5-HT4 receptor antagonist in heart failure. Br J Pharmacol 150:143\u2013152","journal-title":"Br J Pharmacol"},{"key":"179_CR9","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/0024-3205(88)90255-X","volume":"43","author":"GJ Blauw","year":"1988","unstructured":"Blauw GJ, van Brummelen P, van Zwieten PA (1988) Serotonin induced vasodilatation in the human forearm is antagonized by the selective 5-HT3 receptor antagonist ICS 205\u2013930. Life Sci 43:1441\u20131449","journal-title":"Life Sci"},{"key":"179_CR10","first-page":"IV164","volume":"21","author":"KM Bode-Greuel","year":"1990","unstructured":"Bode-Greuel KM, Klisch J, Horvath E, Glaser T, Traber J (1990) Effects of 5-hydroxytryptamine1A-receptor agonists on hippocampal damage after transient forebrain ischemia in the Mongolian gerbil. Stroke 21:IV164\u2013IV166","journal-title":"Stroke"},{"key":"179_CR11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1474-8673.1989.tb00211.x","volume":"9","author":"RA Bond","year":"1989","unstructured":"Bond RA, Craig DA, Charlton KG, Ornstein AG, Clarke DE (1989) Partial agonistic activity of GR43175 at the inhibitory prejunctional 5-HT1-like receptor in rat kidney. J Auton Pharmacol 9:201\u2013210","journal-title":"J Auton Pharmacol"},{"key":"179_CR12","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0028-3908(86)90207-8","volume":"25","author":"PB Bradley","year":"1986","unstructured":"Bradley PB, Engel G, Feniuk W, Fozard JR, Humphrey PP, Middlemiss DN, Mylecharane EJ, Richardson BP, Saxena PR (1986) Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 25:563\u2013576","journal-title":"Neuropharmacology"},{"key":"179_CR13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0304-3959(95)00106-9","volume":"64","author":"P Brandli","year":"1996","unstructured":"Brandli P, Loffler BM, Breu V, Osterwalder R, Maire JP, Clozel M (1996) Role of endothelin in mediating neurogenic plasma extravasation in rat dura mater. Pain 64:315\u2013322","journal-title":"Pain"},{"key":"179_CR14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00210-004-0963-0","volume":"370","author":"T Brattelid","year":"2004","unstructured":"Brattelid T, Qvigstad E, Lynham JA, Molenaar P, Aass H, Geiran O, Skomedal T, Osnes JB, Levy FO, Kaumann AJ (2004) Functional serotonin 5-HT4 receptors in porcine and human ventricular myocardium with increased 5-HT4 mRNA in heart failure. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 370:157\u2013166","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"179_CR15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1113\/jphysiol.1900.sp000821","volume":"26","author":"TG Brodie","year":"1900","unstructured":"Brodie TG (1900) The immediate action of an intravenous injection of blood-serum. J Physiol (London) 26:48\u201371","journal-title":"J Physiol (London)"},{"key":"179_CR16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ejphar.2004.08.050","volume":"502","author":"D Centuri\u00f3n","year":"2004","unstructured":"Centuri\u00f3n D, Glusa E, S\u00e1nchez-L\u00f3pez A, Valdivia LF, Saxena PR, Villal\u00f3n CM (2004) 5-HT7, but not 5-HT2B, receptors mediate hypotension in vagosympathectomized rats. Eur J Pharmacol 502:239\u2013242","journal-title":"Eur J Pharmacol"},{"key":"179_CR17","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/sj.bjp.0703914","volume":"132","author":"D Centuri\u00f3n","year":"2001","unstructured":"Centuri\u00f3n D, Ortiz MI, S\u00e1nchez-L\u00f3pez A, De Vries P, Saxena PR, Villal\u00f3n CM (2001a) Evidence for 5-HT1B\/1D and 5 HT2A receptors mediating constriction of the canine internal carotid circulation. Br J Pharmacol 132:983\u2013990","journal-title":"Br J Pharmacol"},{"key":"179_CR18","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/sj.bjp.0704593","volume":"135","author":"D Centuri\u00f3n","year":"2002","unstructured":"Centuri\u00f3n D, Ortiz MI, Saxena PR, Villal\u00f3n CM (2002) The atypical 5-HT2 receptor mediating tachycardia in pithed rats: pharmacological correlation with the 5-HT2A receptor subtype. Br J Pharmacol 135:1531\u20131539","journal-title":"Br J Pharmacol"},{"key":"179_CR19","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/sj.bjp.0703913","volume":"132","author":"D Centuri\u00f3n","year":"2001","unstructured":"Centuri\u00f3n D, S\u00e1nchez-L\u00f3pez A, De Vries P, Saxena PR, Villal\u00f3n CM (2001b) The GR127935-sensitive 5-HT1 receptors mediating canine internal carotid vasoconstriction: resemblance to the 5-HT1B, but not to the 5-HT1D or 5-ht1F receptor subtype. Br J Pharmacol 132:991\u2013998","journal-title":"Br J Pharmacol"},{"key":"179_CR20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s002100000277","volume":"362","author":"D Centuri\u00f3n","year":"2000","unstructured":"Centuri\u00f3n D, S\u00e1nchez-L\u00f3pez A, Ortiz MI, De Vries P, Saxena PR, Villal\u00f3n CM (2000) Mediation of 5-HT-induced internal carotid vasodilatation in GR127935-and ritanserin-pretreated dogs by 5-HT7 receptors. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 362:169\u2013176","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"179_CR21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0014-2999(93)90622-O","volume":"250","author":"K Chaouche-Teyara","year":"1993","unstructured":"Chaouche-Teyara K, Fournier B, Safar M, Dabir\u00e9 H (1993) Vascular and cardiac effects of alpha-methyl-5-HT and DOI are mediated by different 5-HT receptors in the pithed rat. Eur J Pharmacol 250:67\u201375","journal-title":"Eur J Pharmacol"},{"key":"179_CR22","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3109\/10641969409078025","volume":"16","author":"K Chaouche-Teyara","year":"1994","unstructured":"Chaouche-Teyara K, Fournier B, Safar M, Dabir\u00e9 H (1994) Systemic and regional haemodynamic effects of 1-(2,5-dimethoxy-4-iodo-phenyl)-2-aminopropane (DOI) and alpha-methyl-5-HT, in the anaesthetised rat. Clin Exp Hypertens 16:779\u2013798","journal-title":"Clin Exp Hypertens"},{"key":"179_CR23","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1476-5381.1992.tb12788.x","volume":"107","author":"TM Cocks","year":"1992","unstructured":"Cocks TM, Arnold PJ (1992) 5-Hydroxytryptamine (5-HT) mediates potent relaxation in the sheep isolated pulmonary vein via activation of 5-HT4 receptors. Br J Pharmacol 107:591\u2013596","journal-title":"Br J Pharmacol"},{"key":"179_CR24","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1161\/01.HYP.17.5.593","volume":"17","author":"JD Coffman","year":"1991","unstructured":"Coffman JD (1991) Raynaud\u2019s phenomenon. An update. Hypertension 17:593\u2013602","journal-title":"Hypertension"},{"key":"179_CR25","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/sj.bjp.0703587","volume":"131","author":"ML Cohen","year":"2000","unstructured":"Cohen ML, Schenck K (2000) Contractile responses to sumatriptan and ergotamine in the rabbit saphenous vein: effect of selective 5-HT(1F) receptor agonists and PGF(2alpha). Br J Pharmacol 131:562\u2013568","journal-title":"Br J Pharmacol"},{"key":"179_CR26","first-page":"76","volume":"235","author":"RA Cohen","year":"1985","unstructured":"Cohen RA (1985) Serotonergic prejunctional inhibition of canine coronary adrenergic nerves. J Pharmacol Exp Ther 235:76\u201380","journal-title":"J Pharmacol Exp Ther"},{"key":"179_CR27","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1126\/science.6574604","volume":"221","author":"RA Cohen","year":"1983","unstructured":"Cohen RA, Shepherd JT, Vanhoutte PM (1983) Inhibitory role of the endothelium in the response of isolated coronary arteries to platelets. Science 221:273\u2013274","journal-title":"Science"},{"key":"179_CR28","first-page":"90","volume":"36","author":"A Creite","year":"1869","unstructured":"Creite A (1869) Versuche \u00fcber die Wirkung des Serumeiweisses nach Injection in das Blut. Zeitschrift f\u00fcr Rationelle Medicin 36:90\u2013108","journal-title":"Zeitschrift f\u00fcr Rationelle Medicin"},{"key":"179_CR29","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0014-2999(89)90799-1","volume":"168","author":"H Dabir\u00e9","year":"1989","unstructured":"Dabir\u00e9 H, Chaouche-Teyara K, Cherqui C, Fournier B, Laubie M, Schmitt H (1989a) Characterization of DOI, a putative 5-HT2 receptor agonist in the rat. Eur J Pharmacol 168:369\u2013374","journal-title":"Eur J Pharmacol"},{"key":"179_CR30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0014-2999(89)90143-X","volume":"170","author":"H Dabir\u00e9","year":"1989","unstructured":"Dabir\u00e9 H, Chaouche-Teyara K, Cherqui C, Fournier B, Schmitt H (1989b) DOI is a mixed agonist-antagonist at postjunctional 5-HT2 receptors in the pithed rat. Eur J Pharmacol 170:109\u2013111","journal-title":"Eur J Pharmacol"},{"key":"179_CR31","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.brainres.2007.01.088","volume":"1144","author":"EL Damaso","year":"2007","unstructured":"Damaso EL, Bonagamba LG, Kellett DO, Jordan D, Ramage AG, Machado BH (2007) Involvement of central 5-HT7 receptors in modulation of cardiovascular reflexes in awake rats. Brain Res 1144:82\u201390","journal-title":"Brain Res"},{"key":"179_CR32","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/PL00005359","volume":"359","author":"P Vries De","year":"1999","unstructured":"De Vries P, De Visser PA, Heiligers JPC, Villal\u00f3n CM, Saxena PR (1999) Changes in systemic and regional haemodynamics during 5-HT7 receptor-mediated depressor responses in rats. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 359:331\u2013338","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"179_CR33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0014-2999(98)00762-6","volume":"362","author":"P Vries De","year":"1998","unstructured":"De Vries P, S\u00e1nchez-L\u00f3pez A, Centuri\u00f3n D, Heiligers JP, Saxena PR, Villal\u00f3n CM (1998a) The canine external carotid vasoconstrictor 5-HT1 receptor: blockade by 5-HT1B (SB224289), but not by 5-HT1D (BRL15572) receptor antagonists. Eur J Pharmacol 362:69\u201372","journal-title":"Eur J Pharmacol"},{"key":"179_CR34","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/PL00005034","volume":"356","author":"P Vries De","year":"1997","unstructured":"De Vries P, Villal\u00f3n CM, Heiligers JP, Saxena PR (1997) Nature of 5-HT1-like receptors mediating depressor responses in vagosympathectomized rats; close resemblance to the cloned 5-ht7 receptor. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 356:90\u201399","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"179_CR35","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1038\/sj.bjp.0701770","volume":"123","author":"P Vries De","year":"1998","unstructured":"De Vries P, Villal\u00f3n CM, Heiligers JP, Saxena PR (1998b) Characterization of 5-HT receptors mediating constriction of porcine carotid arteriovenous anastomoses; involvement of 5-HT1B\/1D and novel receptors. Br J Pharmacol 123:1561\u20131570","journal-title":"Br J Pharmacol"},{"key":"179_CR36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0014-2999(88)90350-0","volume":"145","author":"KM Dhasmana","year":"1988","unstructured":"Dhasmana KM, De Boer HJ, Banerjee AK, Saxena PR (1988) Analysis of the tachycardiac response to 5-hydroxytryptamine in the spinal guinea-pig. Eur J Pharmacol 145:67\u201373","journal-title":"Eur J Pharmacol"},{"key":"179_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00169468","volume":"337","author":"JR Docherty","year":"1988","unstructured":"Docherty JR (1988) Investigations of cardiovascular 5-hydroxytryptamine receptor subtypes in the rat. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 337:1\u20138","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"179_CR38","first-page":"45","volume":"13","author":"RM Eglen","year":"1989","unstructured":"Eglen RM, Whiting RL (1989) Comparison of the positive chronotropic response to 5-hydroxytryptamine with beta-adrenoceptor agonists on the guinea pig atria in vitro. J Cardiovasc Pharmacol 13:45\u201351","journal-title":"J Cardiovasc Pharmacol"},{"key":"179_CR39","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1476-5381.1995.tb13240.x","volume":"114","author":"E Ellis","year":"1995","unstructured":"Ellis E, Byrne C, Murphy OE, Tilford NS, Baxter GS (1995) Mediation by 5-hydroxytryptamine2B receptors of endothelium-dependent relaxation in rat jugular vein. Br J Pharmacol 114:400\u2013404","journal-title":"Br J Pharmacol"},{"key":"179_CR40","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/0006-2952(94)90045-0","volume":"48","author":"C Rawadi El","year":"1994","unstructured":"El Rawadi C, Davy M, Midol-Monnet M, Cohen Y (1994) Biochemical characterization of the mechanisms involved in the 5-hydroxytryptamine-induced increase in rat atrial rate. Biochem Pharmacol 48:683\u2013688","journal-title":"Biochem Pharmacol"},{"key":"179_CR41","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/BF01861121","volume":"196","author":"V Erspamer","year":"1940","unstructured":"Erspamer V (1940a) Pharmakologische studien \u00fcber Enteramine. I. Miteilung: \u00dcber die Wirkung von Acetonextrakten der Kaninchenmagenschleimhaut auf den Blutdruck und auf isolierte \u00fcberlebende Organe. Arch Exper Path U Pharmakol 196:343","journal-title":"Arch Exper Path U Pharmakol"},{"key":"179_CR42","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/BF01861122","volume":"196","author":"V Erspamer","year":"1940","unstructured":"Erspamer V (1940b) Pharmakologische studien \u00fcber Enteramine. II. Mitteilung: \u00dcber eigenschaften des Enteramins, sovie \u00fcber die Abgrenzung des Enteramins von der anderen Kreislaufwirksamen Gewebsprodukten. Arch Exper Path U Pharmakol 196:366","journal-title":"Arch Exper Path U Pharmakol"},{"key":"179_CR43","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/BF01861123","volume":"196","author":"V Erspamer","year":"1940","unstructured":"Erspamer V (1940c) Pharmakologische studien \u00fcber Enteramine. III. Mitteilung: \u00dcber das vorhandensein eines enteramin\u00e4hnlichen Stoffes in Milzextrakten. Arch Exper Path U Pharmakol 196:391","journal-title":"Arch Exper Path U Pharmakol"},{"key":"179_CR44","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/169800b0","volume":"169","author":"V Erspamer","year":"1952","unstructured":"Erspamer V, Asero B (1952) Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine. Nature 169:800\u2013801","journal-title":"Nature"},{"issue":"Suppl 1","key":"179_CR45","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1007\/BF01642907","volume":"238","author":"MD Ferrari","year":"1991","unstructured":"Ferrari MD (1991) 5-HT3 receptor antagonists and migraine therapy. J Neurol 238(Suppl 1):S53\u2013S56","journal-title":"J Neurol"},{"key":"179_CR46","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0304-3959(91)90052-Y","volume":"45","author":"MD Ferrari","year":"1991","unstructured":"Ferrari MD, Wilkinson M, Hirt D, Lataste X, Notter M (1991) Efficacy of ICS 205\u2013930, a novel 5-hydroxytryptamine3 (5-HT3) receptor antagonist, in the prevention of migraine attacks. A complex answer to a simple question. ICS 205-930 Migraine Study Group. Pain 45:283\u2013291","journal-title":"Pain"},{"issue":"Suppl 3","key":"179_CR47","doi-asserted-by":"crossref","first-page":"242S","DOI":"10.1378\/chest.114.3_Supplement.242S","volume":"114","author":"AP Fishman","year":"1998","unstructured":"Fishman AP (1998) Etiology and pathogenesis of primary pulmonary hypertension: a perspective. Chest 114(Suppl 3):242S\u2013247S","journal-title":"Chest"},{"key":"179_CR48","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/01.CIR.99.1.156","volume":"99","author":"AP Fishman","year":"1999","unstructured":"Fishman AP (1999) Aminorex to fen\/phen: an epidemic foretold. Circulation 99:156\u2013161","journal-title":"Circulation"},{"key":"179_CR49","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0026-895X(24)26444-0","volume":"57","author":"LW Fitzgerald","year":"2000","unstructured":"Fitzgerald LW, Burn TC, Brown BS, Patterson JP, Corjay MH, Valentine PA, Sun JH, Link JR, Abbaszade I, Hollis JM, Largent BL, Hartig PR, Hollis GF, Meunier PC, Robichaud AJ, Robertson DW (2000) Possible role of valvular serotonin 5-HT2B receptors in the cardiopathy associated with fenfluramine. Mol Pharmacol 57:75\u201381","journal-title":"Mol Pharmacol"},{"key":"179_CR50","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/0028-3908(84)90091-1","volume":"23","author":"JR Fozard","year":"1984","unstructured":"Fozard JR (1984) Neuronal 5-HT receptors in the periphery. Neuropharmacology 23:1473\u20131486","journal-title":"Neuropharmacology"},{"key":"179_CR51","first-page":"111","volume":"329","author":"JR Fozard","year":"1995","unstructured":"Fozard JR (1995) The 5-hydroxytryptamine-nitric oxide connection: the key link in the initiation of migraine. Arch Int Pharmacodyn Ther 329:111\u2013119","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"179_CR52","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF00175026","volume":"350","author":"JR Fozard","year":"1994","unstructured":"Fozard JR, Kalkman HO (1994) 5-Hydroxytryptamine (5-HT) and the initiation of migraine: new perspectives. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 350:225\u2013229","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"179_CR53","first-page":"323","volume":"12","author":"JH Gaddum","year":"1957","unstructured":"Gaddum JH, Picarelli ZP (1957) Two kinds of tryptamine receptors. Br J Pharmacol 12:323\u2013328","journal-title":"Br J Pharmacol"},{"key":"179_CR54","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/sj.bjp.0703341","volume":"130","author":"E Glusa","year":"2000","unstructured":"Glusa E, Pertz HH (2000) Further evidence that 5-HT-induced relaxation of pig pulmonary artery is mediated by endothelial 5-HT2B receptors. Br J Pharmacol 130:692\u2013698","journal-title":"Br J Pharmacol"},{"key":"179_CR55","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/BF00166737","volume":"347","author":"E Glusa","year":"1993","unstructured":"Glusa E, Richter M (1993) Endothelium-dependent relaxation of porcine pulmonary arteries via 5- HT1C-like receptors. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 347:471\u2013477","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"179_CR56","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1046\/j.1468-2982.1996.1607497.x","volume":"16","author":"J Goldstein","year":"1996","unstructured":"Goldstein J, D\u00e4hlof CG, Diener HC, Olesen J, Schellens R, Senard JM, Simard D, Steiner TJ (1996) Alniditan in the acute treatment of migraine attacks: a subcutaneous dose-finding study. Subcutaneous Alniditan Study Group. Cephalalgia 16:497\u2013502","journal-title":"Cephalalgia"},{"key":"179_CR57","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/S0140-6736(01)06347-4","volume":"358","author":"DJ Goldstein","year":"2001","unstructured":"Goldstein DJ, Roon KI, Offen WW, Ramadan NM, Phebus LA, Johnson KW, Schaus JM, Ferrari MD (2001) Selective serotonin1F (5-HT1F) receptor agonist LY334370 for acute migraine: a randomised controlled trial. Lancet 358:1230\u20131234","journal-title":"Lancet"},{"key":"179_CR58","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1468-2982.2001.00208.x","volume":"21","author":"B G\u00f3mez-Mancilla","year":"2001","unstructured":"G\u00f3mez-Mancilla B, Cutler NR, Leibowitz MT, Spierings EL, Klapper JA, Diamond S, Goldstein J, Smith T, Couch JR, Fleishaker J, Azie N, Blunt DE (2001) Safety and efficacy of PNU-142633, a selective 5-HT1D agonist, in patients with acute migraine. Cephalalgia 21:727\u2013732","journal-title":"Cephalalgia"},{"key":"179_CR59","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/BF00511401","volume":"332","author":"M G\u00f6thert","year":"1986","unstructured":"G\u00f6thert M, Schlicker E, Kollecker P (1986) Receptor-mediated effects of serotonin and 5-methoxytryptamine on noradrenaline release in the rat vena cava and in the heart of the pithed rat. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 332:124\u2013130","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"179_CR60","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1111\/j.1476-5381.1995.tb15084.x","volume":"116","author":"P Gupta","year":"1995","unstructured":"Gupta P, Brown D, Butler P, Ellis P, Grayson KL, Land GC, Macor JE, Robson SF, Wythes MJ, Shepperson NB (1995) The in vivo pharmacological profile of a 5-HT1 receptor agonist, CP-122,288, a selective inhibitor of neurogenic inflammation. Br J Pharmacol 116:2385\u20132390","journal-title":"Br J Pharmacol"},{"key":"179_CR61","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0014-2999(97)01055-8","volume":"331","author":"JJ Hagan","year":"1997","unstructured":"Hagan JJ, Slade PD, Gaster L, Jeffrey P, Hatcher JP, Middlemiss DN (1997) Stimulation of 5-HT1B receptors causes hypothermia in the guinea pig. Eur J Pharmacol 331:169\u2013174","journal-title":"Eur J Pharmacol"},{"key":"179_CR62","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0002-9343(99)80156-9","volume":"99","author":"P Herv\u00e9","year":"1995","unstructured":"Herv\u00e9 P, Launay JM, Scrobohaci ML, Brenot F, Simonneau G, Petitpretz P, Poubeau P, Cerrina J, Duroux P, Drouet L (1995) Increased plasma serotonin in primary pulmonary hypertension. Am J Med 99:249\u2013254","journal-title":"Am J Med"},{"key":"179_CR63","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1021\/ja01154a551","volume":"73","author":"KE Hamlin","year":"1951","unstructured":"Hamlin KE, Fischer FE (1951) The synthesis of 5-hydroxytryptamine. J Am Chem Soc 73:5007\u20135008","journal-title":"J Am Chem Soc"},{"key":"179_CR64","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1001\/archinte.1918.00090100041002","volume":"21","author":"K Hirose","year":"1918","unstructured":"Hirose K (1918) Relation between the platelet count of human blood and its vasoconstrictor action after clotting. Arch Int Med 21:604\u2013612","journal-title":"Arch Int Med"},{"key":"179_CR65","first-page":"1","volume":"244","author":"DS Houston","year":"1988","unstructured":"Houston DS, Vanhoutte PM (1988) Comparison of serotonergic receptor subtypes on the smooth muscle and endothelium of the canine coronary artery. J Pharmacol Exp Ther 244:1\u201310","journal-title":"J Pharmacol Exp Ther"},{"key":"179_CR66","first-page":"157","volume":"46","author":"D Hoyer","year":"1994","unstructured":"Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PP (1994) International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev 46:157\u2013203","journal-title":"Pharmacol Rev"},{"key":"179_CR67","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0091-3057(01)00746-8","volume":"71","author":"D Hoyer","year":"2002","unstructured":"Hoyer D, Hannon JP, Martin GR (2002) Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71:533\u2013554","journal-title":"Pharmacol Biochem Behav"},{"key":"179_CR68","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0028-3908(97)00036-1","volume":"36","author":"D Hoyer","year":"1997","unstructured":"Hoyer D, Martin G (1997) 5-HT receptor classification and nomenclature: towards a harmonization with the human genome. Neuropharmacology 36:419\u2013428","journal-title":"Neuropharmacology"},{"key":"179_CR69","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/0165-6147(91)90630-B","volume":"12","author":"PP Humphrey","year":"1991","unstructured":"Humphrey PP, Feniuk W (1991) Mode of action of the anti-migraine drug sumatriptan. Trends Pharmacol Sci 12:444\u2013446","journal-title":"Trends Pharmacol Sci"},{"key":"179_CR70","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1476-5381.1988.tb11630.x","volume":"94","author":"PP Humphrey","year":"1988","unstructured":"Humphrey PP, Feniuk W, Perren MJ, Connor HE, Oxford AW, Coates LH, Butina D (1988) GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein. Br J Pharmacol 94:1123\u20131132","journal-title":"Br J Pharmacol"},{"key":"179_CR71","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1476-5381.1987.tb11338.x","volume":"92","author":"SJ Ireland","year":"1987","unstructured":"Ireland SJ, Jordan CC (1987) Pharmacological characterization of 5-hydroxytryptamine-induced hyperpolarization of the rat cervical ganglion. Br J Pharmacol 92:417\u2013427","journal-title":"Br J Pharmacol"},{"key":"179_CR72","first-page":"482","volume":"346","author":"U Jahnel","year":"1992","unstructured":"Jahnel U, Rupp J, Ertl R, Nawrath H (1992) Positive inotropic response to 5-HT in human atrial but not in ventricular heart muscle. Naunyn- Schmiedeberg\u2019s Arch Pharmacol 346:482\u2013485","journal-title":"Naunyn- Schmiedeberg\u2019s Arch Pharmacol"},{"key":"179_CR73","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/archinte.1918.00090100002001","volume":"21","author":"TC Janeway","year":"1918","unstructured":"Janeway TC, Richardson HB, Park EA (1918) Experiments on the vasoconstrictor action of blood serum. Arch Int Med 21:565\u2013603","journal-title":"Arch Int Med"},{"key":"179_CR74","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1097\/00001756-199707070-00029","volume":"8","author":"KW Johnson","year":"1997","unstructured":"Johnson KW, Schaus JM, Durkin MM, Audia JE, Kaldor SW, Flaugh ME, Adham N, Zgombick JM, Cohen ML, Branchek TA, Phebus LA (1997) 5-HT1F receptor agonists inhibit neurogenic dural inflammation in guinea pigs. Neuroreport 8:2237\u20132240","journal-title":"Neuroreport"},{"key":"179_CR75","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1111\/j.1476-5381.1995.tb16651.x","volume":"116","author":"JF Jones","year":"1995","unstructured":"Jones JF, Martin GR, Ramage AG (1995) Evidence that 5-HT1D receptors mediate inhibition of sympathetic ganglionic transmission in anaesthetized cats. Br J Pharmacol 116:1715\u20131717","journal-title":"Br J Pharmacol"},{"key":"179_CR76","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0024-3205(94)00546-X","volume":"54","author":"HO Kalkman","year":"1994","unstructured":"Kalkman HO (1994) Is migraine prophylactic activity caused by 5-HT2B or 5-HT2C receptor blockade. Life Sci 54:641\u2013644","journal-title":"Life Sci"},{"key":"179_CR77","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1476-5381.1993.tb13937.x","volume":"110","author":"AJ Kaumann","year":"1993","unstructured":"Kaumann AJ (1993) Blockade of human atrial 5-HT4 receptors by GR 113808. Br J Pharmacol 110:1172\u20131174","journal-title":"Br J Pharmacol"},{"key":"179_CR78","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.pharmthera.2005.12.004","volume":"111","author":"AJ Kaumann","year":"2006","unstructured":"Kaumann AJ, Levy FO (2006) 5-Hydroxytryptamine receptors in the human cardiovascular system. Pharmacol Ther 111:674\u2013706","journal-title":"Pharmacol Ther"},{"key":"179_CR79","first-page":"664","volume":"98","author":"AJ Kaumann","year":"1989","unstructured":"Kaumann AJ, Murray KJ, Brown AM, Sanders L, Brown MJ (1989) A receptor for 5-HT in human atrium. Br J Pharmacol 98:664","journal-title":"Br J Pharmacol"},{"key":"179_CR80","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1476-5381.1990.tb14108.x","volume":"100","author":"AJ Kaumann","year":"1990","unstructured":"Kaumann AJ, Sanders L, Brown AM, Murray KJ, Brown MJ (1990) A 5-hydroxytryptamine receptor in human atrium. Br J Pharmacol 100:879\u2013885","journal-title":"Br J Pharmacol"},{"key":"179_CR81","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1113\/jphysiol.2004.076521","volume":"563","author":"DO Kellett","year":"2005","unstructured":"Kellett DO, Ramage AG, Jordan D (2005) Central 5-HT7 receptors are critical for reflex activation of cardiac vagal drive in anaesthetized rats. J Physiol 563:319\u2013331","journal-title":"J Physiol"},{"key":"179_CR82","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1440-1681.1983.tb00222.x","volume":"10","author":"T Kimura","year":"1983","unstructured":"Kimura T, Satoh S (1983) Presynaptic inhibition by serotonin of cardiac sympathetic transmission in dogs. Clin Exp Pharmacol Physiol 10:535\u2013542","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"179_CR83","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/sj.bjp.0703011","volume":"129","author":"ID Knowles","year":"2000","unstructured":"Knowles ID, Ramage AG (2000) Evidence that activation of central 5-HT2B receptors causes renal sympathoexcitation in anaesthetised rats. Br J Pharmacol 129:177\u2013183","journal-title":"Br J Pharmacol"},{"key":"179_CR84","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0014-2999(82)90471-X","volume":"85","author":"MK Krstic","year":"1982","unstructured":"Krstic MK, Katusic ZS (1982) Divergent effects of cyproheptadine and R 50 656, a 5-HT2 antagonist, on the cardiovascular response to 5-hydroxytryptamine in rats. Eur J Pharmacol 85:225\u2013227","journal-title":"Eur J Pharmacol"},{"key":"179_CR85","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1242\/jeb.200.15.2123","volume":"200","author":"K Kuwasawa","year":"1997","unstructured":"Kuwasawa K, Hill R (1997) Evidence for cholinergic inhibitory and serotonergic excitatory neuromuscular transmission in the heart of the bivalve Mercenaria mercenaria. J Exp Biol 200:2123\u20132135","journal-title":"J Exp Biol"},{"key":"179_CR86","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1161\/01.RES.57.1.46","volume":"57","author":"KG Lamping","year":"1985","unstructured":"Lamping KG, Marcus ML, Dole WP (1985) Removal of the endothelium potentiates canine large coronary artery constrictor responses to 5-hydroxytryptamine in vivo. Circ Res 57:46\u201354","journal-title":"Circ Res"},{"key":"179_CR87","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/nm764","volume":"8","author":"JM Launay","year":"2002","unstructured":"Launay JM, Herve P, Peoc\u2019h K, Tournois C, Callebert J, Nebigil CG, Etienne N, Drouet L, Humbert M, Simonneau G, Maroteaux L (2002) Function of the serotonin 5-HT2B receptor in pulmonary hypertension. Nat Med 8:1129\u20131135","journal-title":"Nat Med"},{"issue":"Suppl 1","key":"179_CR88","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF00053424","volume":"4","author":"D Lebrec","year":"1990","unstructured":"Lebrec D (1990) Portal hypertension: serotonin and pathogenesis. Cardiovasc Drugs Ther 4(Suppl 1):33\u201335","journal-title":"Cardiovasc Drugs Ther"},{"key":"179_CR89","first-page":"1567","volume":"50","author":"JE Leysen","year":"1996","unstructured":"Leysen JE, Gommeren W, Heylen L, Luyten WH, van de Weyer I, Vanhoenacker P, Haegeman G, Schotte A, van Gompel P, Wouters R, Lesage AS (1996) Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan. Mol Pharmacol 50:1567\u20131580","journal-title":"Mol Pharmacol"},{"key":"179_CR90","first-page":"244","volume":"17","author":"A Maassen Van Den Brink","year":"1997","unstructured":"Maassen Van Den Brink A, Reekers M, Bax WA, Ferrari MD, Saxena PR (1997) Current and future anti-migraine drugs in the human isolated coronary artery. Cephalalgia 17:244\u2013391","journal-title":"Cephalalgia"},{"key":"179_CR91","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0165-6147(99)01389-9","volume":"20","author":"MR MacLean","year":"1999","unstructured":"MacLean MR (1999) Pulmonary hypertension, anorexigens and 5-HT: pharmacological synergism in action. Trends Pharmacol Sci 20:490\u2013495","journal-title":"Trends Pharmacol Sci"},{"key":"179_CR92","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1152\/jn.00209.2004","volume":"92","author":"S Marinesco","year":"2004","unstructured":"Marinesco S, Kolkman KE, Carew TJ (2004a) Serotonergic modulation in aplysia. I. Distributed serotonergic network persistently activated by sensitizing stimuli. J Neurophysiol 92:2468\u20132486","journal-title":"J Neurophysiol"},{"key":"179_CR93","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1152\/jn.00210.2004","volume":"92","author":"S Marinesco","year":"2004","unstructured":"Marinesco S, Wickremasinghe N, Kolkman KE, Carew TJ (2004b) Serotonergic modulation in aplysia. II. Cellular and behavioral consequences of increased serotonergic tone. J Neurophysiol 92:2487\u20132496","journal-title":"J Neurophysiol"},{"key":"179_CR94","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0163-7258(94)90048-5","volume":"62","author":"GR Martin","year":"1994","unstructured":"Martin GR (1994) Vascular receptors for 5-hydroxytryptamine: distribution, function and classification. Pharmacol Ther 62:283\u2013324","journal-title":"Pharmacol Ther"},{"key":"179_CR95","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF00164867","volume":"336","author":"GR Martin","year":"1987","unstructured":"Martin GR, Leff P, Cambridge D, Barrett VJ (1987) Comparative analysis of two types of 5-hydroxytryptamine receptor mediating vasorelaxation: differential classification using tryptamines. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 336:365\u2013373","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"179_CR96","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0304-3959(96)03137-5","volume":"67","author":"A May","year":"1996","unstructured":"May A, Gijsman HJ, Wallnofer A, Jones R, Diener HC, Ferrari MD (1996) Endothelin antagonist bosentan blocks neurogenic inflammation, but is not effective in aborting migraine attacks. Pain 67:375\u2013378","journal-title":"Pain"},{"key":"179_CR97","first-page":"231","volume":"46","author":"RB McCall","year":"1994","unstructured":"McCall RB, Clement ME (1994) Role of serotonin1A and serotonin2 receptors in the central regulation of the cardiovascular system. Pharmacol Rev 46:231\u2013243","journal-title":"Pharmacol Rev"},{"key":"179_CR98","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1046\/j.1468-2982.2002.00459.x","volume":"22","author":"RB McCall","year":"2002","unstructured":"McCall RB, Huff R, Chio CL, Tenbrink R, Bergh CL, Ennis MD, Ghazal NB, Hoffman RL, Mimeisheri K, Higdon NR, Hall E (2002) Preclinical studies characterizing the anti migraine and cardiovascular effects of the selective 5 HT1D receptor agonist PNU-142633. Cephalalgia 22:799\u2013806","journal-title":"Cephalalgia"},{"key":"179_CR99","doi-asserted-by":"crossref","unstructured":"McQueen DS (1990) Cardiovascular reflexes and 5-hydroxytryptamine. In: Saxena PR, Wallis DI, Wouters W, Bevan P (eds) Cardiovascular pharmacology of 5-hydroxytryptamine, prospective therapeutic applications. Kluwer, Dordrecht, pp 233\u2013245","DOI":"10.1007\/978-94-009-0479-8_17"},{"key":"179_CR100","first-page":"245","volume":"336","author":"GJ Molderings","year":"1987","unstructured":"Molderings GJ, Fink K, Schlicker E, G\u00f6thert M (1987) Inhibition of noradrenaline release via presynaptic 5-HT1B receptors of the rat vena cava. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 336:245\u2013250","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"179_CR101","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0014-2999(89)90461-5","volume":"164","author":"GJ Molderings","year":"1989","unstructured":"Molderings GJ, G\u00f6thert M, Fink K, Roth E, Schlicker E (1989) Inhibition of noradrenaline release in the pig coronary artery via a novel serotonin receptor. Eur J Pharmacol 164:213\u2013222","journal-title":"Eur J Pharmacol"},{"key":"179_CR102","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/BF00169451","volume":"342","author":"GJ Molderings","year":"1990","unstructured":"Molderings GJ, Werner K, Likungu J, G\u00f6thert M (1990) Inhibition of noradrenaline release from the sympathetic nerves of the human saphenous vein via presynaptic 5-HT receptors similar to the 5-HT 1D subtype. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 342:371\u2013377","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"179_CR103","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.revmed.2004.05.007","volume":"25","author":"D Montani","year":"2004","unstructured":"Montani D, Jais X, Ioos V, Sitbon O, Simonneau G, Humbert M (2004) Treatments for pulmonary arterial hypertension. Rev Med Interne 25:720\u2013731","journal-title":"Rev Med Interne"},{"key":"179_CR104","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0014-2999(94)90592-4","volume":"252","author":"A Mor\u00e1n","year":"1994","unstructured":"Mor\u00e1n A, Velasco C, Mart\u00edn ML, San Rom\u00e1n L (1994) Pharmacological characterization of 5-HT receptors in parasympathetic innervation of rat heart. Eur J Pharmacol 252:161\u2013166","journal-title":"Eur J Pharmacol"},{"key":"179_CR105","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/sj.bjp.0702841","volume":"128","author":"I Morecroft","year":"1999","unstructured":"Morecroft I, Heeley RP, Prentice HM, Kirk A, MacLean MR (1999) 5-hydroxytryptamine receptors mediating contraction in human small muscular pulmonary arteries: importance of the 5-HT1B receptor. Br J Pharmacol 128:730\u2013734","journal-title":"Br J Pharmacol"},{"key":"179_CR106","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/sj.bjp.0706839","volume":"149","author":"E Mu\u00f1oz-Islas","year":"2006","unstructured":"Mu\u00f1oz-Islas E, Gupta S, Jim\u00e9nez-Mena LR, Lozano-Cuenca J, S\u00e1nchez-L\u00f3pez A, Centuri\u00f3n D, Mehrotra S, Maassen Van Den Brink A, Villal\u00f3n CM (2006) Donitriptan, but not sumatriptan, inhibits capsaicin-induced canine external carotid vasodilatation via 5-HT1B rather than 5-HT1D receptors. Br J Pharmacol 149:82\u201391","journal-title":"Br J Pharmacol"},{"key":"179_CR107","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.1840140636","volume":"14","author":"F Nevens","year":"1991","unstructured":"Nevens F, Pizcueta MP, Fernandez M, Bosch J, Rodes J (1991) Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in portal hypertensive rats. Hepatology 14:1174\u20131178","journal-title":"Hepatology"},{"key":"179_CR108","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0166-4328(96)00128-3","volume":"73","author":"H Nishio","year":"1996","unstructured":"Nishio H, Fujii A, Nakata Y (1996) Re-examination for pharmacological properties of serotonin-induced tachycardia in isolated guinea-pig atrium. Behav Brain Res 73:301\u2013304","journal-title":"Behav Brain Res"},{"key":"179_CR109","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1254\/jjp.89.242","volume":"89","author":"H Nishio","year":"2002","unstructured":"Nishio H, Morimoto Y, Hisaoka K, Nakata Y, Watanabe T (2002) 5-HT-induced, 5-HT3 receptor-mediated, and ruthenium red- and capsaicin-sensitive positive chronotropic effects in the isolated guinea pig atrium. Jpn J Pharmacol 89:242\u2013248","journal-title":"Jpn J Pharmacol"},{"key":"179_CR110","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1365-2885.1994.tb00236.x","volume":"17","author":"T Obi","year":"1994","unstructured":"Obi T, Kabeyama A, Nishio A (1994) Equine coronary artery responds to 5-hydroxytryptamine with relaxation in vitro. J Vet Pharmacol Ther 17:218\u2013225","journal-title":"J Vet Pharmacol Ther"},{"key":"179_CR111","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMoa030505","volume":"350","author":"J Olesen","year":"2004","unstructured":"Olesen J, Diener HC, Husstedt IW, Goadsby PJ, Hall D, Meier U, Pollentier S, Lesko LM (2004) Calcitonin gene-related peptide receptor antagonist BIBN4096 BS for the acute treatment of migraine. N Engl J Med 350:1104\u20131110","journal-title":"N Engl J Med"},{"key":"179_CR112","first-page":"227","volume":"38","author":"IH Page","year":"1958","unstructured":"Page IH (1958) Serotonin (5-hydroxytryptamine); the last four years. Physiol Rev 38:227\u2013335","journal-title":"Physiol Rev"},{"key":"179_CR113","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1152\/ajplegacy.1953.174.3.436","volume":"174","author":"IH Page","year":"1953","unstructured":"Page IH, McCubbin JW (1953) Modification of vascular response to serotonin by drugs. Am J Physiol 174:436\u2013444","journal-title":"Am J Physiol"},{"key":"179_CR114","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1124\/mi.5.5.10","volume":"5","author":"SJ Peroutka","year":"2005","unstructured":"Peroutka SJ (2005) Neurogenic inflammation and migraine: implications for the therapeutics. Mol Interv 5:304\u2013311","journal-title":"Mol Interv"},{"key":"179_CR115","first-page":"687","volume":"16","author":"SJ Peroutka","year":"1979","unstructured":"Peroutka SJ, Snyder SH (1979) Multiple serotonin receptors: differential binding of . [. 3H]-5-hydroxytryptamine, [3H]-lysergic acid diethylamide and [3H]-spiroperidol. Mol Pharmacol 16:687\u2013699","journal-title":"Mol Pharmacol"},{"key":"179_CR116","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.cardiores.2004.11.017","volume":"65","author":"E Qvigstad","year":"2005","unstructured":"Qvigstad E, Brattelid T, Sjaastad I, Andressen KW, Krobert KA, Birkeland JA, Sejersted OM, Kaumann AJ, Skomedal T, Osnes JB, Levy FO (2005a) Appearance of a ventricular 5-HT4 receptor-mediated inotropic response to serotonin in heart failure. Cardiovasc Res 65:869\u2013878","journal-title":"Cardiovasc Res"},{"key":"179_CR117","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1161\/01.RES.0000176970.22603.8d","volume":"97","author":"E Qvigstad","year":"2005","unstructured":"Qvigstad E, Sjaastad I, Brattelid T, Nunn C, Swift F, Birkeland JA, Krobert KA, Andersen GO, Sejersted OM, Osnes JB, Levy FO, Skomedal T (2005b) Dual serotonergic regulation of ventricular contractile force through 5-HT2A and 5-HT4 receptors induced in the acute failing heart. Circ Res 97:268\u2013276","journal-title":"Circ Res"},{"key":"179_CR118","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0361-9230(01)00612-8","volume":"56","author":"AG Ramage","year":"2001","unstructured":"Ramage AG (2001) Central cardiovascular regulation and 5-hydroxytryptamine receptors. Brain Res Bull 56:425\u2013439","journal-title":"Brain Res Bull"},{"key":"179_CR119","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0021-9258(19)51208-X","volume":"180","author":"MM Rapport","year":"1949","unstructured":"Rapport MM (1949) Serum vasoconstrictor (serotonin). V. The presence of creatinine in the complex: a proposed study of the vasoconstrictor principle. J Biol Chem 180:961\u2013969","journal-title":"J Biol Chem"},{"key":"179_CR120","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0021-9258(18)57355-5","volume":"174","author":"MM Rapport","year":"1948","unstructured":"Rapport MM, Green AA, Page IH (1948a) Partial purification of the vasoconstrictor in beef serum. J Biol Chem 174:735\u2013741","journal-title":"J Biol Chem"},{"key":"179_CR121","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0021-9258(18)57137-4","volume":"176","author":"MM Rapport","year":"1948","unstructured":"Rapport MM, Green AA, Page IH (1948b) Serum vasoconstrictor (serotonin). IV. Isolation and characterization. J Biol Chem 176:1243\u20131251","journal-title":"J Biol Chem"},{"key":"179_CR122","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2125.1999.00851.x","volume":"47","author":"Z Razzaque","year":"1999","unstructured":"Razzaque Z, Heald MA, Pickard JD, Maskell L, Beer MS, Hill RG, Longmore J (1999) Vasoconstriction in human isolated middle meningeal arteries: determining the contribution of 5-HT1B- and 5-HT1F-receptor activation. Br J Clin Pharmacol 47:75\u201382","journal-title":"Br J Clin Pharmacol"},{"issue":"Suppl 1","key":"179_CR123","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF00053422","volume":"4","author":"RS Reneman","year":"1990","unstructured":"Reneman RS, van der Starre PJ (1990) Serotonin and acute cardiovascular disorders. Cardiovasc Drugs Ther 4(Suppl 1):19\u201325","journal-title":"Cardiovasc Drugs Ther"},{"issue":"Suppl 1","key":"179_CR124","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF00053427","volume":"4","author":"JI Robertson","year":"1990","unstructured":"Robertson JI (1990) Carcinoid syndrome and serotonin: therapeutic effects of ketanserin. Cardiovasc Drugs Ther 4(Suppl 1):53\u201358","journal-title":"Cardiovasc Drugs Ther"},{"issue":"Suppl 5","key":"179_CR125","first-page":"S48","volume":"17","author":"JI Robertson","year":"1991","unstructured":"Robertson JI (1991) Serotonergic type-2 (5-HT2) antagonists: a novel class of cardiovascular drugs. J Cardiovasc Pharmacol 17(Suppl 5):S48\u2013S53","journal-title":"J Cardiovasc Pharmacol"},{"key":"179_CR126","first-page":"XLVI","volume":"XII","author":"G Rummo","year":"1889","unstructured":"Rummo G, Bordoni L (1889) Toxicit\u00e9 du s\u00e9rum du sang de l\u2019homme et des animaux \u00e0 l\u2019\u00e9tat normal et dans les maladies par infection. Archiv De Biologie Italienne XII:XLVI\u2013XLVII","journal-title":"Archiv De Biologie Italienne"},{"key":"179_CR127","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/sj.bjp.0705489","volume":"140","author":"A S\u00e1nchez-L\u00f3pez","year":"2003","unstructured":"S\u00e1nchez-L\u00f3pez A, Centuri\u00f3n D, V\u00e1zquez E, Arulmani U, Saxena PR, Villal\u00f3n CM (2003) Pharmacological profile of the 5-HT-induced inhibition of cardioaccelerator sympathetic outflow in pithed rats: correlation with 5-HT1 and putative 5-ht5A\/5B receptors. Br J Pharmacol 140:725\u2013735","journal-title":"Br J Pharmacol"},{"key":"179_CR128","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s00210-003-0842-0","volume":"369","author":"A S\u00e1nchez-L\u00f3pez","year":"2004","unstructured":"S\u00e1nchez-L\u00f3pez A, Centuri\u00f3n D, V\u00e1zquez E, Arulmani U, Saxena PR, Villal\u00f3n CM (2004) Further characterization of the 5-HT1 receptors mediating cardiac sympatho-inhibition in pithed rats: pharmacological correlation with the 5-HT1B and 5-HT1D subtypes. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 369:220\u2013227","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"179_CR129","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1526-4610.1972.hed1202044.x","volume":"12","author":"PR Saxena","year":"1972","unstructured":"Saxena PR (1972) The effects of antimigraine drugs on the vascular responses by 5-hydroxytryptamine and related biogenic substances on the external carotid bed of dogs: Possible pharmacological implications to their antimigraine action. Headache 12:44\u201354","journal-title":"Headache"},{"key":"179_CR130","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0163-7258(94)00005-N","volume":"66","author":"PR Saxena","year":"1995","unstructured":"Saxena PR (1995) Serotonin receptors: subtypes, functional responses and therapeutic relevance. Pharmacol Ther 66:339\u2013368","journal-title":"Pharmacol Ther"},{"key":"179_CR131","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0165-6147(98)01228-0","volume":"19","author":"PR Saxena","year":"1998","unstructured":"Saxena PR, De Vries P, Villal\u00f3n CM (1998) 5-HT1-like receptors: a time to bid goodbye. Trends Pharmacol Sci 19:311\u2013316","journal-title":"Trends Pharmacol Sci"},{"key":"179_CR132","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1517\/13543784.5.5.581","volume":"5","author":"PR Saxena","year":"1996","unstructured":"Saxena PR, Ferrari MD (1996) Pharmacology of antimigraine 5-HT1D receptor agonists. Expert Opin Invest Drugs 5:581\u2013593","journal-title":"Expert Opin Invest Drugs"},{"key":"179_CR133","first-page":"235","volume":"277","author":"PR Saxena","year":"1985","unstructured":"Saxena PR, Lawang A (1985) A comparison of cardiovascular and smooth muscle effects of 5-hydroxytryptamine and 5-carboxamidotryptamine, a selective agonist of 5-HT1 receptors. Arch Int Pharmacodyn Ther 277:235\u2013252","journal-title":"Arch Int Pharmacodyn Ther"},{"issue":"Suppl 7","key":"179_CR134","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1097\/00005344-199001001-00004","volume":"15","author":"PR Saxena","year":"1990","unstructured":"Saxena PR, Villal\u00f3n CM (1990) Cardiovascular effects of serotonin agonists and antagonists. J Cardiovasc Pharmacol 15(Suppl 7):S17\u2013S34","journal-title":"J Cardiovasc Pharmacol"},{"key":"179_CR135","first-page":"387","volume":"252","author":"P Schoeffter","year":"1990","unstructured":"Schoeffter P, Hoyer D (1990) 5-Hydroxytryptamine (5-HT)-induced endothelium-dependent relaxation of pig coronary arteries is mediated by 5-HT receptors similar to the 5- HT1D receptor subtype. J Pharmacol Exp Ther 252:387\u2013395","journal-title":"J Pharmacol Exp Ther"},{"key":"179_CR136","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0014-2999(93)90417-G","volume":"230","author":"RG Schoemaker","year":"1993","unstructured":"Schoemaker RG, Du XY, Bax WA, Bos E, Saxena PR (1993) 5-Hydroxytryptamine stimulates human isolated atrium but not ventricle. Eur J Pharmacol 230:103\u2013105","journal-title":"Eur J Pharmacol"},{"key":"179_CR137","doi-asserted-by":"crossref","first-page":"R782","DOI":"10.1152\/ajpregu.00478.2002","volume":"284","author":"KE Scrogin","year":"2003","unstructured":"Scrogin KE (2003) 5-HT1A receptor agonist 8-OH-DPAT acts in the hindbrain to reverse the sympatholytic response to severe hemorrhage. Am J Physiol Regul Integr Comp Physiol 284:R782\u2013R791","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"179_CR138","doi-asserted-by":"crossref","first-page":"R1776","DOI":"10.1152\/ajpregu.2000.279.5.R1776","volume":"279","author":"KE Scrogin","year":"2000","unstructured":"Scrogin KE, Johnson AK, Brooks VL (2000) Methysergide delays the decompensatory responses to severe hemorrhage by activating 5-HT1A) receptors. Am J Physiol Regul Integr Comp Physiol 279:R1776\u2013R1786","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"179_CR139","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1476-5381.1994.tb14781.x","volume":"111","author":"SL Shepheard","year":"1994","unstructured":"Shepheard SL, Jordan D, Ramage AG (1994) Comparison of the effects of IVth ventricular administration of some tryptamine analogues with those of 8-OH-DPAT on autonomic outflow in the anaesthetized cat. Br J Pharmacol 111:616\u2013624","journal-title":"Br J Pharmacol"},{"key":"179_CR140","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0028-3908(94)00153-J","volume":"34","author":"SL Shepheard","year":"1995","unstructured":"Shepheard SL, Williamson DJ, Williams J, Hill RG, Hargreaves RJ (1995) Comparison of the effects of sumatriptan and the NK1 antagonist CP-99,994 on plasma extravasation in Dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats. Neuropharmacology 34:255\u2013261","journal-title":"Neuropharmacology"},{"key":"179_CR141","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00002826-199619020-00001","volume":"19","author":"B Silver","year":"1996","unstructured":"Silver B, Weber J, Fisher M (1996) Medical therapy for ischemic stroke. Clin Neuropharmacol 19:101\u2013128","journal-title":"Clin Neuropharmacol"},{"key":"179_CR142","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0166-4328(96)00089-7","volume":"73","author":"M Skingle","year":"1996","unstructured":"Skingle M, Beattie DT, Scopes DI, Starkey SJ, Connor HE, Feniuk W, Tyers MB (1996) GR127935: a potent and selective 5-HT1D receptor antagonist. Behav Brain Res 73:157\u2013161","journal-title":"Behav Brain Res"},{"key":"179_CR143","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1476-5381.1991.tb12280.x","volume":"102","author":"MJ Sumner","year":"1991","unstructured":"Sumner MJ (1991) Characterization of the 5-HT receptor mediating endothelium-dependent relaxation in porcine vena cava. Br J Pharmacol 102:938\u2013942","journal-title":"Br J Pharmacol"},{"key":"179_CR144","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.pharmthera.2005.12.006","volume":"111","author":"DR Thomas","year":"2006","unstructured":"Thomas DR (2006) 5-ht5A receptors as a therapeutic target. Pharmacol Ther 111:707\u2013714","journal-title":"Pharmacol Ther"},{"key":"179_CR145","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0306-4522(93)90469-V","volume":"55","author":"KB Thor","year":"1993","unstructured":"Thor KB, Nickolaus S, Helke CJ (1993) Autoradiographic localization of 5-hydroxytryptamine1A, 5-hydroxytryptamine1B and 5-hydroxytryptamine1C\/2 binding sites in the rat spinal cord. Neuroscience 55:235\u2013252","journal-title":"Neuroscience"},{"key":"179_CR146","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1476-5381.1993.tb12821.x","volume":"108","author":"M Tramontana","year":"1993","unstructured":"Tramontana M, Giuliani S, Del BE, Lecci A, Maggi CA, Evangelista S, Geppetti P (1993) Effects of capsaicin and 5-HT3 antagonists on 5-hydroxytryptamine-evoked release of calcitonin gene-related peptide in the guinea-pig heart. Br J Pharmacol 108:431\u2013435","journal-title":"Br J Pharmacol"},{"key":"179_CR147","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s00210-004-0947-0","volume":"370","author":"LF Valdivia","year":"2004","unstructured":"Valdivia LF, Centuri\u00f3n D, Arulmani U, Saxena PR, Villal\u00f3n CM (2004) 5-HT1B receptors, \u03b12A\/2C- and, to a lesser extent, \u03b11-adrenoceptors mediate the external carotid vasoconstriction to ergotamine in vagosympathectomized dogs. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 370:46\u201353","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"179_CR148","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0014-2999(92)90854-W","volume":"222","author":"EM Gelderen Van","year":"1992","unstructured":"Van Gelderen EM, Saxena PR (1992) Effect of N(G)-nitro-L-arginine methyl ester on the hypotensive and hypertensive responses to 5-hydroxytryptamine in pithed rats. Eur J Pharmacol 222:185\u2013191","journal-title":"Eur J Pharmacol"},{"key":"179_CR149","first-page":"223","volume":"42","author":"JM Nueten Van","year":"1983","unstructured":"Van Nueten JM (1983) 5-hydroxytryptamine and precapillary vessels. Fed Proc 42:223\u2013227","journal-title":"Fed Proc"},{"key":"179_CR150","first-page":"217","volume":"218","author":"JM Nueten Van","year":"1981","unstructured":"Van Nueten JM, Janssen PA, Van Beek J, Xhonneux R, Verbeuren TJ, Vanhoutte PM (1981) Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors. J Pharmacol Exp Ther 218:217\u2013230","journal-title":"J Pharmacol Exp Ther"},{"key":"179_CR151","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/BF02450276","volume":"19","author":"M Vialli","year":"1933","unstructured":"Vialli M, Erspamer V (1933) Cellule enterocromaffine e cellule basigranulose acidofile nei vertebrati. Ztschr Zellforsch 19:743\u2013773","journal-title":"Ztschr Zellforsch"},{"key":"179_CR152","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s002100000256","volume":"361","author":"CM Villal\u00f3n","year":"2000","unstructured":"Villal\u00f3n CM, Centuri\u00f3n D, Bravo G, De Vries P, Saxena PR, Ortiz MI (2000) Further pharmacological analysis of the orphan 5-HT receptors mediating feline vasodepressor responses: close resemblance to the 5-HT7 receptor. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 361:665\u2013671","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"179_CR153","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/S0024-3205(99)00126-5","volume":"64","author":"CM Villal\u00f3n","year":"1999","unstructured":"Villal\u00f3n CM, Centuri\u00f3n D, Fern\u00e1ndez MM, Mor\u00e1n A, S\u00e1nchez-L\u00f3pez A (1999a) 5-Hydroxytryptamine inhibits the tachycardia induced by selective preganglionic sympathetic stimulation in pithed rats. Life Sci 64:1839\u20131847","journal-title":"Life Sci"},{"key":"179_CR154","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/sj.bjp.0701020","volume":"120","author":"CM Villal\u00f3n","year":"1997","unstructured":"Villal\u00f3n CM, Centuri\u00f3n D, Luj\u00e1n-Estrada M, Terr\u00f3n JA, S\u00e1nchez-L\u00f3pez A (1997a) Mediation of 5-HT-induced external carotid vasodilatation in GR 127935- pretreated vagosympathectomized dogs by the putative 5-HT7 receptor. Br J Pharmacol 120:1319\u20131327","journal-title":"Br J Pharmacol"},{"key":"179_CR155","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/sj.bjp.0701907","volume":"124","author":"CM Villal\u00f3n","year":"1998","unstructured":"Villal\u00f3n CM, Centuri\u00f3n D, Rabelo G, De Vries P, Saxena PR, S\u00e1nchez-L\u00f3pez A (1998) The 5-HT1-like receptors mediating inhibition of sympathetic vasopressor outflow in the pithed rat: operational correlation with the 5-HT1A, 5-HT1B and 5-HT1D subtypes. Br J Pharmacol 124:1001\u20131011","journal-title":"Br J Pharmacol"},{"key":"179_CR156","first-page":"199","volume":"45","author":"CM Villal\u00f3n","year":"2002","unstructured":"Villal\u00f3n CM, Centuri\u00f3n D, Valdivia LF, De Vries P, Saxena PR (2002) An introduction to migraine: from ancient treatment to functional pharmacology and antimigraine therapy. Proc West Pharmacol Soc 45:199\u2013210","journal-title":"Proc West Pharmacol Soc"},{"key":"179_CR157","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejphar.2003.11.026","volume":"484","author":"CM Villal\u00f3n","year":"2004","unstructured":"Villal\u00f3n CM, Centuri\u00f3n D, Willems EW, Arulmani U, Saxena PR, Valdivia LF (2004) 5-HT1B receptors and \u03b12A\/2C. -adrenoceptors mediate external carotid vasoconstriction to dihydroergotamine. Eur J Pharmacol 484:287\u2013290","journal-title":"Eur J Pharmacol"},{"key":"179_CR158","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0024-3205(95)02008-7","volume":"57","author":"CM Villal\u00f3n","year":"1995","unstructured":"Villal\u00f3n CM, Contreras J, Ram\u00edrez-San Juan E, Castillo C, Perusqu\u00eda M, L\u00f3pez-Mu\u00f1oz FJ, Terr\u00f3n JA (1995a) 5-Hydroxytryptamine inhibits pressor responses to preganglionic sympathetic nerve stimulation in pithed rats. Life Sci 57:803\u2013812","journal-title":"Life Sci"},{"key":"179_CR159","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1111\/j.1476-5381.1995.tb15143.x","volume":"116","author":"CM Villal\u00f3n","year":"1995","unstructured":"Villal\u00f3n CM, Contreras J, Ram\u00edrez-San Juan E, Castillo C, Perusqu\u00eda M, Terr\u00f3n JA (1995b) Characterization of prejunctional 5-HT receptors mediating inhibition of sympathetic vasopressor responses in the pithed rat. Br J Pharmacol 116:3330\u20133336","journal-title":"Br J Pharmacol"},{"key":"179_CR160","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/sj.bjp.0702324","volume":"126","author":"CM Villal\u00f3n","year":"1999","unstructured":"Villal\u00f3n CM, De Vries P, Rabelo G, Centuri\u00f3n D, S\u00e1nchez-L\u00f3pez A, Saxena PR (1999b) Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B\/1D receptors and \u03b12-adrenoceptors. Br J Pharmacol 126:585\u2013594","journal-title":"Br J Pharmacol"},{"key":"179_CR161","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S1359-6446(97)01055-6","volume":"2","author":"CM Villal\u00f3n","year":"1997","unstructured":"Villal\u00f3n CM, De Vries P, Saxena PR (1997b) Serotonin receptors as cardiovascular targets. Drug Discov Today 2:294\u2013300","journal-title":"Drug Discov Today"},{"key":"179_CR162","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1476-5381.1990.tb14073.x","volume":"100","author":"CM Villal\u00f3n","year":"1990","unstructured":"Villal\u00f3n CM, Den Boer MO, Heiligers JP, Saxena PR (1990) Mediation of 5-hydroxytryptamine-induced tachycardia in the pig by the putative 5-HT4 receptor. Br J Pharmacol 100:665\u2013667","journal-title":"Br J Pharmacol"},{"key":"179_CR163","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1476-5381.1991.tb12140.x","volume":"102","author":"CM Villal\u00f3n","year":"1991","unstructured":"Villal\u00f3n CM, Den Boer MO, Heiligers JP, Saxena PR (1991) Further characterization, by use of tryptamine and benzamide derivatives, of the putative 5-HT4 receptor mediating tachycardia in the pig. Br J Pharmacol 102:107\u2013112","journal-title":"Br J Pharmacol"},{"key":"179_CR164","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/sj.bjp.0701260","volume":"121","author":"CM Villal\u00f3n","year":"1997","unstructured":"Villal\u00f3n CM, Heiligers JP, Centuri\u00f3n D, De Vries P, Saxena PR (1997c) Characterization of putative 5-HT7 receptors mediating tachycardia in the cat. Br J Pharmacol 121:1187\u20131195","journal-title":"Br J Pharmacol"},{"key":"179_CR165","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/BF00170827","volume":"354","author":"CM Villal\u00f3n","year":"1996","unstructured":"Villal\u00f3n CM, S\u00e1nchez-L\u00f3pez A, Centuri\u00f3n D (1996) Operational characteristics of the 5-HT1-like receptors mediating external carotid vasoconstriction in vagosympathectomized dogs: close resemblance to the 5-HT1D receptor subtype. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 354:550\u2013556","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"179_CR166","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s002100000333","volume":"363","author":"CM Villal\u00f3n","year":"2001","unstructured":"Villal\u00f3n CM, S\u00e1nchez-L\u00f3pez A, Centuri\u00f3n D, Saxena PR (2001) Unravelling the pharmacological profile of the canine external carotid vasodilator \u201c5-HT1-like\u201d receptors: coexistence of sympatho-inhibitory 5-HT1B and postjunctional 5-HT7 receptors. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 363:73\u201380","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"179_CR167","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0014-2999(93)90539-T","volume":"240","author":"CM Villal\u00f3n","year":"1993","unstructured":"Villal\u00f3n CM, Terr\u00f3n JA, Hong E (1993) Role of 5-HT1-like receptors in the increase in external carotid blood flow induced by 5-hydroxytryptamine in the dog. Eur J Pharmacol 240:9\u201320","journal-title":"Eur J Pharmacol"},{"key":"179_CR168","first-page":"H944","volume":"276","author":"SW Watts","year":"1999","unstructured":"Watts SW, Fink GD (1999) 5-HT2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt-hypertensive rats. Am J Physiol 276:H944\u2013H952","journal-title":"Am J Physiol"},{"key":"179_CR169","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF01661741","volume":"LXV","author":"O Weiss","year":"1896","unstructured":"Weiss O (1896) Ueber die Wirkungen von Blutserum-Injectionen ins Blut. Archiv f\u00fcr die Gesamte Physiologie des Menschen und der Thiere LXV:215\u2013230","journal-title":"Archiv f\u00fcr die Gesamte Physiologie des Menschen und der Thiere"},{"key":"179_CR170","first-page":"683","volume":"252","author":"H Wilson","year":"1990","unstructured":"Wilson H, Coffman WJ, Cohen ML (1990) 5-Hydroxytryptamine3 receptors mediate tachycardia in conscious instrumented dogs. J Pharmacol Exp Ther 252:683\u2013688","journal-title":"J Pharmacol Exp Ther"},{"key":"179_CR171","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0028-3908(96)00149-9","volume":"36","author":"XJ Yu","year":"1997","unstructured":"Yu XJ, Cutrer FM, Moskowitz MA, Waeber C (1997) The 5-HT1D receptor antagonist GR-127,935 prevents inhibitory effects of sumatriptan but not CP-122,288 and 5-CT on neurogenic plasma extravasation within guinea pig dura mater. Neuropharmacology 36:83\u201391","journal-title":"Neuropharmacology"},{"key":"179_CR172","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0165-1838(88)90111-7","volume":"22","author":"AP Yusof","year":"1988","unstructured":"Yusof AP, Coote JH (1988) Excitatory and inhibitory actions of intrathecally administered 5-hydroxytryptamine on sympathetic nerve activity in the rat. J Auton Nerv Syst 22:229\u2013236","journal-title":"J Auton Nerv Syst"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-007-0179-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-007-0179-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-007-0179-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T11:38:48Z","timestamp":1737373128000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-007-0179-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,17]]},"references-count":172,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2007,10,4]]}},"alternative-id":["179"],"URL":"https:\/\/doi.org\/10.1007\/s00210-007-0179-1","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,17]]}}}